Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) shares rose 5.6% during mid-day trading on Wednesday . The company traded as high as $1.81 and last traded at $1.81. Approximately 477,721 shares changed hands during trading, a decline of 54% from the average daily volume of 1,032,505 shares. The stock had previously closed at $1.71. Wall […]
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $0.40-$0.50 for the period, compared to the consensus earnings per share estimate of $0.50. The company issued revenue guidance of $2.25 billion-$2.35 billion, compared to the consensus revenue estimate of $2.31 billion. Analysts […]
Should You Buy or Sell Amneal Pharmaceuticals Stock? Get The Latest AMRX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) have earned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective […]
Shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) traded up 9.4% during mid-day trading on Wednesday . The stock traded as high as $3.36 and last traded at $3.36. 12,141 shares were traded during mid-day trading, a decline of 98% from the average session volume of 690,960 shares. The stock had previously closed at […]